-
Barclays Has 5 Takeaways From Meeting With Laboratory Corp Of America's Management
Monday, August 29, 2016 - 3:14pm | 346Read More...Barclays said Laboratory Corp. of America Holdings (NYSE: LH) management noted it sees some sustainable tailwinds for volume growth in its lab business, while reimbursement visibility remains good through the end of 2017. Analysts, including Jack Meehan who had investor meetings with LabCorp...
-
Markets Mixed As Oil Continues To Drop
Monday, November 3, 2014 - 5:37pm | 1023Read More...U.S. markets were mixed to start the week as the price of crude oil traded at levels it hasn't seen in more than two years following Saudi Arabia's announcement it will cut the selling price of oil to the U.S. and raise prices for other locations. Economic data released today showed...
-
Merger Monday Mania Roundup
Monday, November 3, 2014 - 12:42pm | 339Read More...Investors and traders were treated to a plethora of merger and acquisition activity Monday morning. Here is a round-up of notable moves. Publicis has agreed to acquire Sapient Corporation (NASDAQ: SAPE) for $3.7 billion in cash, or $25 per share. The offer represents an approximate 44 percent...
-
Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB)
Saturday, November 24, 2012 - 6:02pm | 768Read More...This weekend's Barron's features an article that suggests investors seeking bargains should look to Europe, despite the economy climate there. Here is a quick look at four stocks of European companies traded on U.S. exchanges that have seen their share prices climb more than 50 percent year to date...
-
Deutsche Bank Maintains Buy Rating On CVD, ICLR
Thursday, April 14, 2011 - 8:10am | 64Read More...Deutsche Bank is retaining its Buy rating on Covance Inc. (NYSE: CVD), “who is best positioned to capitalize on strategic deal momentum,” and ICON (NASDAQ: ICLR), “whose valuation discount to peers could unwind given potential operating margin expansion post recent restructuring.” Covance closed...
-
Deutsche Bank Reiterates Buy Rating On CVD And ICLR
Tuesday, April 5, 2011 - 8:03am | 115Read More...Deutsche Bank is reiterating its Buy rating on shares of Covance Inc. (NYSE: CVD) and ICON plc (NASDAQ: ICLR). “Key takeaways from the Annual Partnerships in Clinical Trials Conference: 1) Vendor consolidation amongst biopharma clients (from 10-to-15 to 2-to-4) and momentum towards strategic deals...
-
Piper Jaffray Raises PT On Covance To $64
Friday, January 28, 2011 - 8:44am | 27Read More...Piper Jaffray has raised the price target on Covance, Inc. (NYSE: CVD) from $43 to $64 and maintains its Neutral rating.
-
Jefferies Raises PT On Covance To $52
Friday, January 28, 2011 - 8:30am | 27Read More...Jefferies & Company has raised the price target on Covance, Inc. (NYSE: CVD) from $45 to $52 and maintains its Hold rating.
-
Covance Reports Significant Cost Initiatives
Thursday, November 4, 2010 - 7:29am | 210Read More...Goldman Sachs has published a research report on Covance, Inc. (NYSE: CVD) after the company reported 3Q EPS directly in-line with Goldman Sachs and Consensus. In the report, Goldman Sachs writes "CVD reported adjusted 3Q EPS of $0.50 (which excluded ~$0.01-$0.02 from 2Q cost actions), versus GS/...
-
Piper Jaffray's Field Trip To Sharp Healthcare
Friday, September 24, 2010 - 8:01am | 262Read More...Piper Jaffray has published a Health Care Services: Information Technology report with key takeaways which are as follows: "Sharp [Healthcare] is one of about a dozen hospitals that have both Cerner and Allscripts. Getting the two vendors to cooperate has been challenging at times. At the root of...
